- Target
- PD-L2
- Reactivity
- Human,Mouse,Rat
- Application
- WB,IF,ELISA
- MW(Calculated)
- 31kD
- MW(Observed)
- 28kD
- Host Species
- Rabbit
- Isotype
- IgG,Kappa
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:200-1:1000;IF 1:200-1:1000;ELISA 1:5000-1:20000;
- Form
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Source
- --
- Purification
- Protein A
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- --
- Clonality
- Monoclonal
- Clone No.
- PT1804R
- Immunogen
- --
- Sequence
- --
- Specificity
- Endogenous
- Gene Name
- PDCD1LG2 B7DC CD273 PDCD1L2 PDL2
- Protein Name
- Programmed cell death 1 ligand 2 (PD-1 ligand 2) (PD-L2) (PDCD1 ligand 2) (Programmed death ligand 2) (Butyrophilin B7-DC) (B7-DC) (CD antigen CD273)
- Other Name
- Programmed cell death 1 ligand 2;PD-1 ligand 2;PD-L2;PDCD1 ligand 2;Programmed death ligand 2;Butyrophilin B7-DC;B7-DC;CD antigen CD273;
- Organism-1
- Human
- Gene ID-1
- 80380
- SwissProt-1
- Q9BQ51
- Organism-2
- Mouse
- Gene ID-2
- 58205
- SwissProt-2
- Q9WUL5
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Highly expressed in heart, placenta, pancreas, lung and liver and weakly expressed in spleen, lymph nodes and thymus.